Am J Transplant, Volume 5, Suppl 3 Archives - Page 149 of 170 - ATC Abstracts

2015 American Transplant Congress
Outcomes of Patients With Hepatocellular Carcinoma Receiving a Donation After Cardiac Death Liver Graft
W. Goldkamp,¹ J. Vanatta,^2,3 S. Nair,^2,3 E. Wong,³ N. Dbouk.^2,3
¹Internal Medicine, The Universty of Tennessee Health Science Center, Memphis, TN; ²Surgery, The Universty of Tennessee Health Science Center, Memphis, TN; ³Methodist Universty Hospital Transplant Institute, Memphis, TN.
Background: Recent data suggests that patients with Hepatocellular carcinoma (HCC) who receive a donation after cardiac death (DCD) graft have inferior graft and patient survival…
2015 American Transplant Congress
Does Higher Cost Improve Outcome in Pediatric Liver Transplantation?
J. Minneman, J. Grijalva, S. Rangel, H. Kim, K. Vakili.
Surgery, Boston Children's Hospital, Boston, MA.
Examine the relationship between transplant-related total cost and 1-year graft failure and patient mortality rate for liver transplantation at freestanding children's hospitals.Using the Pediatric Health…
2015 American Transplant Congress
New Insights in Clinical and Genetic Determinants of Longitudinal Dose-Corrected CNI Exposure in Children After Renal Transplantation
N. Knops,¹ M. van Dyck,¹ E. Levtchenko,¹ D. Kuypers,² J. Herman.¹
¹Pediatric Nephrology and Solid Organ Transplantation, University Hospitals Leuven, Leuven, Belgium; ²Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.
Purpose: Calcineurin-inhibitors (CNI) have a narrow therapeutic index and dosing is difficult due to inter- and intra-individual variation in pharmacokinetics (PK). Polymorphisms in genes involved…
2015 American Transplant Congress
Living Donor Transplant Rates in Children Are Declining
D. Keith, A. Nishio Lucar, G. Vranic.
University of Virginia, Charlottesville, VA.
Living donor (LD) transplant rates have been declining since 2004 in adult candidates. We sought to determine if this trend is also occurring in pediatric…
2015 American Transplant Congress
The Explore Transplant Program in GA: Is Historical Access to Transplantation Associated With Kidney Transplant Knowledge and Preparedness to Educate ERSD Patients?
J. Gander,¹ C. Isenhour,¹ L. McPherson,¹ M. Basu,¹ B. Tao,¹ K. Smtih,¹ S. Pastan,¹ A. Waterman,² R. Patzer.¹
¹Emory University, Atlanta; ²University of California, Los Angeles.
IntroductionDialysis facilities play a key role in educating end stage renal disease patients on kidney transplantation (KTx). We aimed to investigate the association between historical…
2015 American Transplant Congress
Can Gene-Expression Profiling Score Help Explain the Adverse Clinical Outcomes Seen in Gender-Mismatched Heart Transplants?
N. Sulemanjee,¹ P. Prasad,² T. Wolf,² V. Thohan,¹ J. Teuteberg.³
¹Aurora Research Institute, St. Luke's Medical Center, Milwaukee, WI; ²CareDx, Inc., Brisbane, CA; ³University of Pittsburgh Medical Center, Pittsburgh, PA.
Background: Gene-expression profiling (GEP) testing, in conjunction with clinical assessment, is an established laboratory test intended to aid in the identification of acute cellular rejection…
2015 American Transplant Congress
Boosting the Adaptive Immune Response Prevents the High Incidence of Herpes Zoster After Lung or Heart Transplantation
N. van Besouw,¹ S. Roest,² J. Zuijderwijk,¹ R. de Kuiper,¹ J. van Weezel,³ A. van der Eijk,⁴ W. Weimar,¹ P. Hal,³ O. Manintveld.²
¹Internal Medicine - Transplantation, Erasmus MC, Rotterdam, Netherlands; ²Cardiology, Erasmus MC, Rotterdam, Netherlands; ³Respiratory Medicine, Erasmus MC, Rotterdam, Netherlands; ⁴Viroscience, Erasmus MC, Rotterdam, Netherlands.
Purpose Primary varicella zoster virus (VZV) infection causes varicella and lifelong latent infection in ganglia from which it may reactivate leading to herpes zoster (HZ).…
2015 American Transplant Congress
Can Post-Transplant C-Peptide Be Used as an Indicator of Pancreas Graft Failure?
R. Carrico,¹ J. Fridell,² J. Odorico,³ R. Stratta,⁴ K. Tyler,¹ S. Niederhaus,⁵ R. Kandaswamy,⁶ J. Fisher,⁷ O. Olaitan,⁸ M. Mujtaba.²
¹UNOS, Richmond, VA; ²Indiana Univ School of Medicine, Indianapolis, IN; ³Univ Wisconsin Hospital and Clinics, Madison, WI; ⁴Wake Forest Baptist Medical Center, Winston-Salem, NC; ⁵Univ of Maryland Medical System, Baltimore, MD; ⁶Univ of MN Medical Center, Minneapolis, MN; ⁷Scripps Green Hospital, La Jolla, CA; ⁸Rush Univ Medical Center, Chicago, IL.
Background: The OPTN Pancreas Transplantation Committee is attempting to define pancreas graft failure and performed a study to determine if C-peptide corresponds to pancreas graft…
2015 American Transplant Congress
Donor Derived Transmission Events in 2014: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)
D. Kaul,¹ S. Covington,² S. Taranto,² M. Green,¹ C. Wolfe.¹
¹OPTN Ad Hoc Disease Transmission Advisory Committee, Richmond, VA; ²United Network for Organ Sharing, Richmond, VA.
Background: The OPTN DTAC, a multidisciplinary committee, evaluates potential donor derived transmission events (PDDTE), including infections (I) & malignancies (M), to assess for donor transmitted…
2015 American Transplant Congress
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of Graft Failure and Mortality Among Kidney Transplant Recipients
P. Clayton,^1,2,3 W. Lim,^1,4 S. Chadban.^1,2,3
¹Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia; ²Transplantation, Royal Prince Alfred Hospital, Sydney, Australia; ³Sydney Medical School, University of Sydney, Sydney, Australia; ⁴Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia.
Purpose: Graft loss and death are generally late events after kidney transplantation, and trials designed to assess the impact of interventions on these outcomes are…